Compositions and methods for diagnosis and treatment of cancer

US10370433B2 · kind B2 · utility

Assignee

• BioNTech AG · DE

Inventors

• Ugur Sahin · Mainz, DE
• Joycelyn Wüstehube-Lausch · Worms, DE
• Markus Fiedler · Bodenwerder, DE
• Matin Daneschdar · Budenheim, DE
• Hans-Ulrich Schmoldt · Darmstadt, DE

Key dates

• Filing date: Mar 15, 2016
• Grant date: Aug 6, 2019
• Expiry date: Mar 15, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Y304/21026
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates to the diagnosis and treatment of cancerous diseases, in particular cancerous diseases expressing Seprase (Fap-alpha; fibroblast activation protein alpha). More particularly, the invention concerns peptides targeting Seprase.